Source:http://linkedlifedata.com/resource/pubmed/id/17654042
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
2007-7-26
|
pubmed:abstractText |
Indomethacin is one of non-steroidal anti-inflammatory drugs that are commonly used clinically and often cause gastric mucosal injury as a side effect. Generation of reactive oxygen species (ROS) and activation of apoptotic signaling are involved in the pathogenesis of indomethacin-induced gastric mucosal injury. Thioredoxin-1 (Trx-1) is a small redox-active protein with anti-oxidative activity and redox-regulating functions. The aim of this study was to investigate the protective effect of Trx-1 against indomethacin-induced gastric mucosal injury. Trx-1 transgenic mice displayed less gastric mucosal damage than wild type (WT) C57BL/6 mice after intraperitoneal administration of indomethacin. Administration of recombinant human Trx-1 (rhTrx-1) or transfection of the Trx-1 gene reduced indomethacin-induced cytotoxicity in rat gastric epithelial RGM-1 cells. Pretreatment with rhTrx-1 suppressed indomethacininduced ROS production and downregulation of phosphorylated Akt in RGM-1 cells. Survivin, a member of inhibitors of apoptosis proteins family, was downregulated by indomethacin, which was suppressed in Trx-1 transgenic mice or by administration of rhTrx-1 in RGM-1 cells. Trx-1 inhibits indomethacin-induced apoptotic signaling and gastric ulcer formation, suggesting that it may have a preventive and therapeutic potential against indomethacin-induced gastric injury.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents...,
http://linkedlifedata.com/resource/pubmed/chemical/Indomethacin,
http://linkedlifedata.com/resource/pubmed/chemical/Reactive Oxygen Species,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Thioredoxins,
http://linkedlifedata.com/resource/pubmed/chemical/Txn1 protein, mouse
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1071-5762
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
41
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
861-9
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:17654042-Animals,
pubmed-meshheading:17654042-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:17654042-Apoptosis,
pubmed-meshheading:17654042-Cell Line,
pubmed-meshheading:17654042-Gastric Mucosa,
pubmed-meshheading:17654042-Indomethacin,
pubmed-meshheading:17654042-Mice,
pubmed-meshheading:17654042-Mice, Transgenic,
pubmed-meshheading:17654042-Rats,
pubmed-meshheading:17654042-Reactive Oxygen Species,
pubmed-meshheading:17654042-Recombinant Proteins,
pubmed-meshheading:17654042-Thioredoxins
|
pubmed:year |
2007
|
pubmed:articleTitle |
Thioredoxin-1 attenuates indomethacin-induced gastric mucosal injury in mice.
|
pubmed:affiliation |
Department of Biological Responses, Kyoto University, Institute for Virus Research, Sakyo, Kyoto, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|